[Trial of a new synthetic fluidifying and analeptic agent: sobrerol. Its use in inflammatory bronchopneumopathies].
作者信息
Marchioni C F, Monzali G
出版信息
Clin Ter. 1972 Jan 31;60(2):135-42.
PMID:4401338
Abstract
摘要
相似文献
1
2
[Research on respiratory function in chronic bronchopneumopathies and its changes in relation to special therapies].
Arch Sci Med (Torino). 1968 Oct;125(10):506-15.
3
4
[Respiratory stimulation with vanillic acid diethylamide in chronic bronchitis and respiratory insufficiency].
Med Klin. 1970 Sep 4;65(36):1570-6.
5
[Secretolytic effect of sobrelol and improvement of pulmonary ventilation in patients with chronic pulmonary tuberculosis associated with chronic bronchitis].
G Ital Mal Torace. 1971 May-Jun;25(3):145-61.
6
[Clinical trial of a new substance with secretolytic action].
Minerva Med. 1969 Sep 19;60(75):3525-44.
7
8
[D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses].[右甲吗喃治疗急慢性支气管肺部炎症]
Minerva Med. 1973 May 25;64(37):1995-2002.
9
[Clinical considerations on a recent preparation with bronchial secretolytic action].
Minerva Med. 1969 Sep 22;60(76):3583-93.
10
[Sobrerol for the treatment of chronic obstructive bronchopneumopathies (clinical and functional observations)].
Policlinico Med. 1971 Mar-Apr;78(2):82-90.
引用本文的文献
1
Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?黏液促排剂在上呼吸道感染治疗中的应用：仅称其为黏液促排剂是否恰当？
Clin Med Insights Ear Nose Throat. 2019 Jan 9;12:1179550618821930. doi: 10.1177/1179550618821930. eCollection 2019.
Zotero 插件